Embedded Files
The results were published Monday in The Lancet, a medical journal. According to the published report, the researchers have now completed phase one of their “single-blind, randomized controlled trial,” which has involved the testing of a possible vaccine on volunteers in five sites in Great Britain, all healthy adults between the ages of 18 and 55. “We are seeing very good immune responses, not just on neutralizing antibodies but of T-cells as well,” Adrian Hill, head of Oxford’s Jenner Institute, said in an interview with Bloomberg on Monday. “We’re stimulating both arms of the immune system.”All of us tradespeople just sat back & watched the show, as she told him “to get off the damn phone,”when he realised what had happened he took her out the door for an early lunch, we didn’t see him for the rest of the day…
Page updated
Google Sites
Report abuse